Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years


With savvy stock-picking and a bit of patience, building wealth isn't as difficult as it is often made out to be. This is because quality businesses grow their revenue and profits, which makes their shares more valuable over time.

Shares of (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. Let's dig into what the two pharmaceutical companies accomplished that drove their stock prices higher, and whether they can keep up those strong performances. 

With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS).

Continue reading


Source Fool.com

Astrazeneca ADR Aktie

72,50 €
0,69 %
Die Astrazeneca ADR Aktie verzeichnet heute einen leichten Gewinn von 0,69 %.

Like: 0
AZN
Teilen

Kommentare